GeneDx Holdings Corp
WGS123.110USD
+6.700+5.76%
Close 08/13, 16:00（ET）Quotes delayed by 15 min
3.53BMarket Cap
LossP/E TTM
More Details of GeneDx Holdings Corp Company
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.
Company Info
Ticker SymbolWGS
Company nameGeneDx Holdings Corp
IPO dateSep 04, 2020
CEOMs. Katherine A. Stueland
Number of employees1000
Security typeOrdinary Share
Fiscal year-endSep 04
Address333 Ludlow Street
CitySTAMFORD
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code06902
Phone18887291206
Websitehttps://sema4.com/
Ticker SymbolWGS
IPO dateSep 04, 2020
CEOMs. Katherine A. Stueland
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
+179.38%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
4.12K
-54.90%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
+179.38%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
4.12K
-54.90%
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Patients with third party insurance
68.06M
78.13%
Institutional customers
17.60M
20.21%
Other
1.36M
1.56%
Self pay patients
96.00K
0.11%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Patients with third party insurance
68.06M
78.13%
Institutional customers
17.60M
20.21%
Other
1.36M
1.56%
Self pay patients
96.00K
0.11%
Shareholding Stats
Updated: 8 hours ago
Updated: 8 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Casdin Capital, LLC
12.28%
Corvex Management LP
10.13%
Fidelity Management & Research Company LLC
9.23%
William Blair Investment Management, LLC
5.68%
Icahn School of Medicine at Mount Sinai
4.78%
other
57.91%
Shareholders
Shareholders
Proportion
Casdin Capital, LLC
12.28%
Corvex Management LP
10.13%
Fidelity Management & Research Company LLC
9.23%
William Blair Investment Management, LLC
5.68%
Icahn School of Medicine at Mount Sinai
4.78%
other
57.91%
Shareholder Types
Shareholders
Proportion
Hedge Fund
34.61%
Investment Advisor
33.99%
Investment Advisor/Hedge Fund
30.22%
Corporation
10.71%
Research Firm
5.58%
Individual Investor
1.75%
Pension Fund
1.22%
Bank and Trust
0.39%
Sovereign Wealth Fund
0.24%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
2023Q1
296
21.58M
684.27%
+3.47M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Casdin Capital, LLC
3.53M
12.36%
--
--
May 05, 2025
Corvex Management LP
2.91M
10.19%
+434.85K
+17.58%
May 05, 2025
Fidelity Management & Research Company LLC
2.65M
9.29%
+2.25M
+558.69%
Mar 31, 2025
William Blair Investment Management, LLC
1.19M
4.17%
+518.99K
+77.46%
Mar 31, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.81%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.8%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.04M
3.64%
-41.94K
-3.89%
Mar 31, 2025
Summit Partners Public Asset Management, LLC
1.20M
4.21%
-224.44K
-15.73%
Mar 31, 2025
The Vanguard Group, Inc.
1.03M
3.6%
+23.46K
+2.34%
Mar 31, 2025
Goldman Sachs & Company, Inc.
1.03M
3.62%
-31.91K
-3.00%
Mar 31, 2025
View more
Related ETFs
Updated: Wed, Aug 6
Updated: Wed, Aug 6
Name
Proportion
Global X Genomics & Biotechnology ETF
3.13%
Innovator IBD 50 Fund ETF
3.09%
SPDR S&P Health Care Services ETF
2.64%
Harbor Health Care ETF
1.75%
Franklin Genomic Advancements ETF
1.19%
Simplify Health Care ETF
1.03%
Hypatia Women CEO ETF
0.78%
Fidelity Enhanced Small Cap ETF
0.67%
First Trust Small Cap Growth AlphaDEX Fund
0.57%
First Trust Active Factor Small Cap ETF
0.51%
View more
Global X Genomics & Biotechnology ETF
Proportion3.13%
Innovator IBD 50 Fund ETF
Proportion3.09%
SPDR S&P Health Care Services ETF
Proportion2.64%
Harbor Health Care ETF
Proportion1.75%
Franklin Genomic Advancements ETF
Proportion1.19%
Simplify Health Care ETF
Proportion1.03%
Hypatia Women CEO ETF
Proportion0.78%
Fidelity Enhanced Small Cap ETF
Proportion0.67%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.57%
First Trust Active Factor Small Cap ETF
Proportion0.51%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Date
Type
Ratio
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
Apr 28, 2023
Merger
33<1
